How does breakthrough brain science become real treatment for patients? In this episode, we sit down with Dr. Daniela Tropea, Associate Professor of Molecular Psychiatry at Trinity College Dublin, to explore how cutting-edge neuroscience research is being translated into life-changing therapies for mental health and neurodevelopmental disorders.
As the leader of Trinity’s Translational Neuroscience Laboratory, Dr. Tropea has helped reshape our understanding of brain plasticity and growth factors — including her influential work on insulin-like growth factor 1 (IGF-1). Her research directly contributed to the development of Trofinetide, the first FDA-approved treatment for Rett Syndrome, and continues to inspire new therapeutic possibilities for conditions like Fragile X and Phelan-McDermid Syndrome.
In this conversation, we dive into:
Dr. Tropea is also a celebrated educator and international collaborator, recognized for innovation in teaching and mentorship — and for making complex science accessible to broader communities.
Want to explore more of her work? Visit her profile at Trinity College Dublin, review her latest neuroscience publications, or connect with her directly via email: Daniela.Tropea@tcd.ie
Episode also available on Apple Podcasts: https://apple.co/38oMlMr
🛍️ Recommended Products & Reads from This Episode:
Note: These are affiliate links. If you make a purchase through them, we may earn a small commission at no extra cost to you. It helps support the podcast. Thank you!
Podcast: Play in new window | Download | Embed